BAM
SGYP

Brave Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Brave Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-500
Closed -$2K – 447
2015
Q1 		$2K Buy
+500
New +$1.63K ﹤0.01% 415

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Brave Asset Management's SGYP Position: Q2 2015 in Review

Brave Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2015, closing a stake of 500 shares — an estimated $2K sold.

Brave Asset Management first reported a position in SGYP in Q1 2015 and held it in 1 quarter. The position peaked at $2K in Q1 2015. 123 funds tracked by Wall St. Rank hold SGYP as of Q2 2015.

  • Brave Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2015 after selling out during the quarter.
  • Brave Asset Management sold 500 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2015, an estimated $2K.
  • Brave Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 1 quarter.
  • Brave Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2K in Q1 2015.
  • 123 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2015.

Based on Brave Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.